INS and metabolic disease: One potential mechanism by which the gut microbiome influences metabolic disease and T2D is via the fermentation of indigestible fibers into SCFAs (i.e., acetate, propionate, and butyrate) and others, and these metabolites can regulate blood glucose levels and insulin release [36].